U.S. Judge Denies Sanofi-Aventis (France)'s Request to Get Lovenox Generic Rival Made by Novartis AG Blocked; Sanofi to Continue Fight

August 26, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

LONDON, Aug 26 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) said it would continue a legal battle in the United States against a generic version of its blood clot preventer Lovenox, despite a court rebuff.

Twitter
LinkedIn
Facebook
Email
Print

Legal

Sanofi (France) Novartis